Cancer drugs firm Blueprint Medicines has gained a second US approval, with its Gavreto (pralsetinib) daily pill that targets non-small...
Read moreRoche announced U.S. FDA approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker...
Read moreValneva SE, a specialty vaccine company focused on prevention against diseases with major unmet needs, announced a vaccine partnership with...
Read moreMerck is making a major investment into Bothwell, Washington-based Seattle Genetics with two strategic oncology deals. Seattle Genetics’ shares rocketed...
Read moreIn the largest deal in its 33-year history, Gilead Sciences has agreed to pay $21 billion to acquire Immunomedics and...
Read moreAmgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GSK, Institut De Recherches Servier, Janssen, Merck, and Novartis — inked an agreement to...
Read moreClinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health...
Read moreRipeta and Wellcome are pleased to announce a collaborative effort to assess data and code availability in the manuscripts of...
Read moreThanks to its novel real-cum-virtual Marketplace concept euroPLX 73 Vienna will be one of the first pharma partnering events, if not...
Read moreNational Science and Technology Development Agency Thailand (NSTDA) is implementing the Government’s Thailand 4.0 initiative to promote strategic biotechnology growth...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.